Crossmark

Management of anoperineal lesions in Crohn’s disease: a French National Society of Coloproctology national consensus

Crossref DOI link: https://doi.org/10.1007/s10151-018-1906-y

Published Online: 2019-01-02

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Bouchard, D.

Pigot, F.

Staumont, G.

Siproudhis, L.

Abramowitz, L.

Benfredj, P.

Brochard, C.

Fathallah, N.

Faucheron, J.-L.

Higuero, T.

Panis, Y.

de Parades, V.

Vinson-Bonnet, B.

Laharie, D.
License Information

Text and Data Mining valid from 2018-12-01
More Information

Article History

Received: 10 October 2018

Accepted: 7 December 2018

First Online: 2 January 2019

Compliance with ethical standards

:

: Dominique Bouchard is the recipient of fees for education and consulting from Abbvie, François Pigot is the recipient of fees for lectures from Abbvie, Laurent Siproudhis is the recipient of fees for consulting, teaching and research from Abbvie, Ferring, MSD and Takeda, Laurent Abramowitz is the recipient of fees for research from Abbvie and Takeda, Jean-Luc Faucheron is the recipient of fees for consulting and research from AMI and Medtronic, David Laharie is the recipient of fees for consulting and research from Abbvie, Janssen, MSD and Takeda, Ghislain Staumont, Paul Benfredj, Charlène Brochard, Nadia Fathallah, Thierry Higuero, Yves Panis, Vincent de Parades, and Béatrice Vinson-Bonnet have no conflict of interest or financial ties to disclose.

: This article does not contain any studies with human participants performed by any of the authors.

: For this type of study formal consent is not required.